Advertisement

Topics

Teva Announces Exclusive Launch of Generic Axiron in the United States

14:45 EDT 19 Aug 2017 | Topix

Teva Pharmaceutical Industries Ltd., today announced the launch of generic Axiron1 topical solution CIII, 30 mg/1.5 mL, in the U.S. Testosterone topical solution CIII is a prescription medicine used to treat adult males who have low or no testosterone due to certain medical conditions. It is supplied in a metered dose pump with an underarm applicator.

Original Article: Teva Announces Exclusive Launch of Generic Axiron in the United States

NEXT ARTICLE

More From BioPortfolio on "Teva Announces Exclusive Launch of Generic Axiron in the United States"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Endocrinology
Diabetes Diabetes Endocrine Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several groups of h...